The GLP-1 class, which includes rival Novo Nordisks Ozempic and Wegovy, has enjoyed unprecedented demand in recent years, with some analysts projecting annual global sales of $150 billion by the end of the decade
In addition, we are unpersuaded by commenters' arguments that diversity, equity and inclusion programs are necessary for achieving positive health outcomes or maintaining trust in healthcare institutions: rather, as we stated in the CY 2026 OPPS/ASC proposed rule, we believe that patients and the larger society have a compelling need for medical education to be focused primarily on excellence and delivering the best possible care to patients
De Pergola G, Zamboni M, Pannacciulli N, Turcato E, Giorgino F, Armellini F, Logoluso F, Sciaraffia M, Bosello O, Giorgino R
Reach out, stay in touch, and join us as we support individuals in achieving their goals
Transfer to other containers is not recommended as it may compromise sterility and could lead to dosing errors
FDA-Approved Peptides (Clinical Use) Semaglutide / Tirzepatide Type 2 diabetes and weight management Bremelanotide Hypoactive sexual desire disorder Tesamorelin HIV-associated lipodystrophy Liraglutide Chronic weight management 2
